 |
| March
27, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
- Geron: Appointment of New Members to Its
Board of Directors More
- Kodiak Sciences: Positive Topline Results
in GLOW2, the Second Phase 3 Study in
Diabetic Retinopathy, Demonstrating
Superiority of Zenkuda (tarcocimab tedromer)
Over Sham More
More* More*
More*
- Long Bridge Medical: Receives Clearance From
FDA to Initiate the U.S. Pivotal Clinical
Study for LensOne Prosthetic Capsular Bag More
- Novo Nordisk: FDA-Approved GLP-1s Now
Available With Hims & Hers More
- Parker Institute for Cancer Immunotherapy:
Appoints Bolyn Hubby as Chief of Staff to
Strengthen Organization Excellence During
Period of Growth More
- Xaira Therapeutics: Appointment of Rachel
Lane, Ph.D., as Senior Vice President,
Business Development and Operations More
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Apogee Therapeutics: Closing of Public
Offering and Full Exercise of the
Underwriters’ Option to Purchase Additional
Shares for Gross Proceeds of $403 Million More
- Endologix to Close Production Facility,
Lay Off 31 People More
- Innovent: 2025 Annual Results and Business
Updates More
- Iridex: Fourth Quarter and Full Year 2025
Financial Results
More
- Kyverna Therapeutics: Business Update and
Fourth Quarter and Full Year 2025 Financial
Results More
- Rani Therapeutics: Fourth Quarter and Full
Year 2025 Financial Results; Corporate Update
More
- Senti
Bio: Fourth Quarter and Full Year 2025
Financial Results and Provides a Corporate
Update More
- Vivani Medical: Fourth Quarter and Full Year
2025 Financial Results and Provides Business
Update More
|
|
 |
| San
Francisco's most flexible contract
vivarium lab space: Start with a
few cages and grow. |
|
Learn More
→ |
|
|
|
- Allogene’s Off-the-Shelf CAR-T Is Nearing
an Early but Pivotal Study Readout More*
Podcast
- Genentech Walks the Walk in Lupus as Sponsor
of Annual Awareness and Fundraising Event
More
- Husband-Wife Serial Entrepreneurs, a $75
Million Raise and the Value of ‘Psychic
Income’ More*
- More on FDA Clearing Denali Drug in ‘Clear
Step’ for Rare Disease Biotechs More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- From Seed to Series C: What
Investors Look for Beyond the Science More
- Hiring Outlook: February Brings First YOY
Job Increase Since 2022 More
- ICYMI: CEO’s Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO’s Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- Idorsia Looks for Another CEO — Again;
Former Jazz Exec Makes a Comeback More*
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- 10 Companies Hiring in San Francisco and
South San Francisco More
- The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
